Prolactinomas
NEJM 362:1219-1226, Klibanski,A., 2010
Clinicopath Conf, Pituitary Adenoma
NEJM 359:2367-2377, Case 37-2008, 2008
Prolactinoma
NEJM 349:2035-2041, Schlechte,J.A., 2003
SUNCT Syndrome in Two Patient with Prolactinomas and Bromocriptine-Induced Attacks
Neurol 58:1698-1699, Massiou,H.,et al, 2002
Diagnosis, Treatment, and Outcome of Pituitary Tumors and Other Abnormal Intrasellar Masses, Retrospective Analysis of 353 Patients
Medicine 78:236-269, Gsponer,J.,et al, 1999
Management of Pituitary Tumors
Ann Int Med 129:472-483, Shimon,I.&Melmed,S., 1998
Relapse of Hyperprolactinemia Revisited
NEJM 329:1357, Serri,O.,et al, 1993
Twelve Cases of Pituitary Apoplexy
Arch Int Med 152:1893-1899, Vidal,E.,et al, 1992
Diagnosis and Management of Hormone-Secreting Pituitary Adenomas
NEJM 324:822-831, Klibanski,A.&Zervas,N.T., 1991
Treatment of Prolactin-Secreting Pituitary Macroadenomas with the Long-Acting Non-Ergot Dopamine Agonist CV 205-502
Ann Int Med 112:668-673, Vance,M.L.,et al, 1990
The'Incidentaloma'of the Pituitary Gland is Neurosurgery Required
JAMA 263:2772-2776, Reincke,M.,et al, 1990
The Pituitary"Incidentaloma"
Ann Int Med 112:925-931, Molitch,M.E.&Russell,E.J., 1990
Hyperprolactinaemia, Common and Treatable
BMJ 297:701-702, Hartog,M.&Hull,M.G.R., 1988
Giant Invasive Prolactinomas
Am J Med 83:995-1002, Murphy,F.Y.,et al, 1987
Low Doses of Dopamine Agonists in the Long-Term Treatment of Macroprolactinomas
NEJM 313:656-659, Liuzzi,A.,et al, 1985